Trial Profile
A Multicenter, Randomized, Double-blinded, Placebo-controlled Pilot Study to Evaluate the Efficacy and Safety of Rebamipide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis (REPAIR)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary) ; Lansoprazole
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- Acronyms REPAIR
- 04 May 2016 New trial record